SIREN : 491582441
PHARMACIE DES ALIZES is a French company founded 19 years ago, specialized in the sector Activités des sièges sociaux. Based in CRACH (56950), this company of category PME shows in 2022 a net income positive of 284 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C |
| Net income | 284 067 € | 172 895 € | 166 441 € | 185 548 € | 141 887 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C |
| Net margin | N/C | N/C | N/C | N/C | N/C |
In 2022, PHARMACIE DES ALIZES generates positive net income of 284 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 142 k€ -> 284 k€.
284 067 €
The debt ratio (= Financial debt / Equity x 100) stands at 73%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
72.54%
50.501%
23.0%
In 2022, the debt ratio of PHARMACIE DES ALIZES (72.54) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2022, the financial autonomy of PHARMACIE DES ALIZES (50.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 223.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
223.772
In 2022, the liquidity ratio of PHARMACIE DES ALIZES (223.77) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Based on 107 transactions of similar company sales in 2022, the value of PHARMACIE DES ALIZES is estimated at 1 724 411 € (range 1 110 734€ - 2 925 585€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 107 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PHARMACIE DES ALIZES with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of PHARMACIE DES ALIZES is not publicly disclosed (confidential accounts filed with INPI).
Yes, PHARMACIE DES ALIZES generated a net profit of 284 k€ in 2022.
The headquarters of PHARMACIE DES ALIZES is located in CRACH (56950), in the department Morbihan.
The tax return of PHARMACIE DES ALIZES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHARMACIE DES ALIZES operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.